Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 644.45
+6.55 (1.03%)
Nov 12, 2026, 3:29 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 51.87 billion as of November 12, 2026. It is the 13,824th most valuable company in the world and the 838th biggest in India. Its market cap has decreased by 13.30% in one year.
Market Cap
51.87B
Enterprise Value
51.17B
Revenue
8.79B
Global Rank
Country Rank
#838 India
PE Ratio
29.28
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 51.87B, an increase of 64.88%. That is a compound annual growth rate of 10.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 51.87B | -14.24% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 602.96B |
| Anthem Biosciences | 537.71B |
| OneSource Specialty Pharma | 182.31B |
| Concord Biotech | 125.33B |
| Blue Jet Healthcare | 103.32B |
| Zota Health Care | 45.35B |
| Dishman Carbogen Amcis | 27.44B |
| Panacea Biotec | 21.98B |